Compare Adaptive Biotechnologies Corp (ADPT) vs American Electric Power Company Inc (AEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs American Electric Power Company Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while American Electric Power Company Inc trades at $123.61 (market cap $66.87B). The key difference: American Electric Power Company Inc is far larger — about 16.5× Adaptive Biotechnologies Corp's market cap, and American Electric Power Company Inc pays a 3.09% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | AEP | |
|---|---|---|
Market Cap | $4.05B | $66.87B |
Sector | Health | Utilities |
52-Week High | $25.45 | $138.69 |
52-Week Low | $12.30 | $106.44 |
Enterprise Value | $4.12B | $119.77B |
Dividend Yield | — | 3.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About American Electric Power Company Inc
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →
